Takeda Pharmaceutical (TAK) Current Assets (2017 - 2026)

Takeda Pharmaceutical's Current Assets history runs 10 years deep, the most recent figure standing at $19.7 billion for Q1 2026.

• In Q1 2026, Current Assets rose 19.25% year-over-year to $19.7 billion; the TTM figure through Mar 2026 stood at $19.7 billion (up 19.25% YoY), while the FY2026 annual figure was $20.5 billion, up 24.04% from the prior year.
• Current Assets was $19.7 billion for Q1 2026 at Takeda Pharmaceutical, down from $20.3 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $22.3 billion in Q1 2022 to a low of $16.4 billion in Q4 2023.
• Historically, Current Assets has averaged $18.8 billion across 5 years, with a median of $18.4 billion in 2022.
• The sharpest annual moves came in 2023 and 2024: Current Assets dropped 18.77% in 2023, then gained 20.1% in 2024.
• A 5-year view of Current Assets shows it stood at $18.4 billion in 2022, then declined by 10.58% to $16.4 billion in 2023, then climbed by 10.26% to $18.1 billion in 2024, then grew by 11.77% to $20.3 billion in 2025, then slipped by 2.68% to $19.7 billion in 2026.
• The last three Current Assets figures came in at $19.7 billion (Q1 2026), $20.3 billion (Q4 2025), and $19.8 billion (Q3 2025), per Business Quant data.